BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Giorgio A, De Angelis P, Cheli M, Vajro P, Iorio R, Cananzi M, Riva S, Maggiore G, Indolfi G, Calvo PL, Nicastro E, D’antiga L. Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: A multicentre national study. Digestive and Liver Disease 2019;51:1179-84. [DOI: 10.1016/j.dld.2019.02.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Gattini D, Cifuentes LI, Torres-Robles R, Gana JC. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2020;3:CD011573. [PMID: 32133620 DOI: 10.1002/14651858.CD011573.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
2 Cifuentes LI, Gattini D, Torres-Robles R, Gana JC. Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2021;1:CD011973. [PMID: 33498095 DOI: 10.1002/14651858.CD011973.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Bersani I, Piersigilli F, Iacona G, Savarese I, Campi F, Dotta A, Auriti C, Di Stasio E, Garcovich M. Incidence of umbilical vein catheter-associated thrombosis of the portal system: A systematic review and meta-analysis. World J Hepatol 2021; 13(11): 1802-1815 [PMID: 34904047 DOI: 10.4254/wjh.v13.i11.1802] [Reference Citation Analysis]
4 Salloum S, Alemu K, Abedalweli R. An unusual presentation of portal vein thrombosis in a 2-year-old girl. Am J Emerg Med 2021;41:262.e1-3. [PMID: 32829990 DOI: 10.1016/j.ajem.2020.08.015] [Reference Citation Analysis]
5 Puri Y, Gunasekaran V, Palanisamy SK, Elangovan B, Krishna P, Balasubramanian B, Ananth A, Reddy MS, Rela M. A Novel Technique of Physiological Portal Inflow Augmentation During Liver Transplantation for Yerdel Grade 4 Portal Vein Thrombosis. Liver Transpl. 2020;26:294-298. [PMID: 31724287 DOI: 10.1002/lt.25680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Gana JC, Cifuentes LI, Gattini D, Torres-Robles R. Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2020;11:CD011803. [PMID: 33164205 DOI: 10.1002/14651858.CD011803.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Grama A, Pîrvan A, Sîrbe C, Burac L, Ştefănescu H, Fufezan O, Bordea MA, Pop TL. Extrahepatic Portal Vein Thrombosis, an Important Cause of Portal Hypertension in Children. J Clin Med 2021;10:2703. [PMID: 34207387 DOI: 10.3390/jcm10122703] [Reference Citation Analysis]
8 Bhatt MD, Chan AK. Venous thrombosis in neonates. Fac Rev 2021;10:20. [PMID: 33718937 DOI: 10.12703/r/10-20] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zielsdorf S, Narayanan L, Kantymyr S, Barbetta A, Kwon Y, Etesami K, Genyk Y, Emamaullee J. Surgical shunts for extrahepatic portal vein obstruction in pediatric patients: a systematic review. HPB (Oxford) 2021;23:656-65. [PMID: 33388243 DOI: 10.1016/j.hpb.2020.11.1149] [Reference Citation Analysis]
10 Kassam AF, Goddard GR, Johnston ME, Cortez AR, Trout AT, Jenkins TM, Miethke AG, Campbell KM, Bezerra JA, Balistreri WF, Nathan JD, Alonso MH, Tiao GM, Bondoc AJ. Natural Course of Pediatric Portal Hypertension. Hepatol Commun 2020;4:1346-52. [PMID: 32923837 DOI: 10.1002/hep4.1560] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cifuentes LI, Gattini D, Torres-Robles R, Gana JC. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2021;1:CD011561. [PMID: 33522602 DOI: 10.1002/14651858.CD011561.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Luoto TT, Koivusalo AI, Pakarinen MP. Long-term Outcomes and Health Perceptions in Pediatric-onset Portal Hypertension Complicated by Varices. J Pediatr Gastroenterol Nutr 2020;70:628-34. [PMID: 31990868 DOI: 10.1097/MPG.0000000000002643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
13 Gattini D, Cifuentes LI, Torres-Robles R, Gana JC. Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2020;1:CD011659. [PMID: 31922266 DOI: 10.1002/14651858.CD011659.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Di Giorgio A, Nicastro E, Agazzi R, Colusso M, D’antiga L. Long-term Outcome of Transjugular Intrahepatic Portosystemic Shunt in Children With Portal Hypertension. Journal of Pediatric Gastroenterology & Nutrition 2020;70:615-22. [DOI: 10.1097/mpg.0000000000002597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]